Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection

Aliment Pharmacol Ther. 2022 Aug;56(3):546-547. doi: 10.1111/apt.17079.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenine / therapeutic use
  • Alanine
  • Antiviral Agents / pharmacokinetics
  • Antiviral Agents / therapeutic use
  • Female
  • HIV Infections* / drug therapy
  • Hepatitis B, Chronic* / drug therapy
  • Humans
  • Milk, Human
  • Mothers
  • Tenofovir / analogs & derivatives

Substances

  • Antiviral Agents
  • Tenofovir
  • tenofovir alafenamide
  • Adenine
  • Alanine